Table 1 Clinical and demographic data of the study population used for ex vivo gene expression analysis (age, sex, diagnosis, Thompson grade [29], vertebral level)
Sample | Sex | Age | Diagnosis | Grade | Level | Region |
|---|---|---|---|---|---|---|
1 | M | 31 | DDD | II | L5/S1 | NP |
2a | F | 39 | Trauma | II | C4/5 | AF |
2b | F | 39 | Trauma | II | C4/5 | NP |
3a | F | 57 | Trauma | II | Th10/11 | AF |
3b | F | 57 | Trauma | II | Th10/11 | NP |
4a | F | 70 | Trauma | II | Th12/L1 | AF |
4b | F | 70 | Trauma | II | Th12/L1 | NP |
5a | M | 29 | Trauma | III | L1/2 | AF |
5b | M | 29 | Trauma | III | L1/2 | NP |
6a | F | 34 | DDD | III | L4/5 | AF |
6b | F | 34 | DDD | III | L4/5 | NP |
7a | M | 41 | DDD | III | C4/5 | AF |
7b | M | 41 | DDD | III | C4/5 | NP |
8 | M | 46 | DDD | III | L5/6 | NP |
9a | M | 25 | DDD | IV | L5/S1 | AF |
9b | M | 25 | DDD | IV | L5/S1 | NP |
10 | M | 44 | DDD | IV | L5/S1 | AF+NP |
11 | M | 50 | DDD | IV | L5/S1 | AF+NP |
12 | M | 55 | Spondylodesis | IV | C3/4 | AF+NP |
13a | F | 58 | Spondylodesis | IV | C5/6 | AF |
13b | F | 58 | Spondylodesis | IV | C5/6 | NP |
14 | M | 37 | DDD | V | L5/S1 | AF+NP |
15a | F | 41 | DDD | V | L3/4 | AF |
15b | F | 41 | DDD | V | L3/4 | NP |
16a | M | 67 | DDD | V | L5/S1 | AF |
16b | M | 67 | DDD | V | L5/S1 | NP |
17a | M | 72 | DDD | V | L4/5 | AF |
17b | M | 72 | DDD | V | L4/5 | NP |